Viemed Healthcare (VMD) Capital Leases (2023 - 2024)
Viemed Healthcare (VMD) reported Capital Leases of $28000.0 for Q2 2024, down 80.42% on a YoY basis from $143000.0 in Q3 2023, and down 70.53% quarter-over-quarter from $95000.0 in Q1 2024.
Viemed Healthcare (VMD) Capital Leases (2023 - 2024) Analysis & Trends
Viemed Healthcare has reported Capital Leases for 2 years, with the latest figure at $28000.0 in Q2 2024.
- For the quarter ending Q2 2024, Capital Leases fell 80.42% year-over-year to $28000.0; the trailing twelve-month figure through Jun 2024 stood at $28000.0 (down 80.42% YoY), and the FY2023 full-year result was $132000.0, changed N/A from the prior year.
- Capital Leases for Q2 2024 stood at $28000.0, down from $95000.0 in the prior quarter.
- The five-year high for Capital Leases was $180000.0 in Q3 2023, with the low at $28000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 410.03 Mn | 402.20 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Jun 30, 2023 | 143,000.00 |